Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 3825507)

Published in Acta Neuropathol on January 01, 1986

Authors

B Schwerer, H Lassmann, K Kitz, H Bernheimer

Articles citing this

Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol (1988) 2.93

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest (1996) 1.74

Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol (1988) 1.41

Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry (1999) 1.33

Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol (2011) 1.12

Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (1991) 1.04

Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infect Immun (1995) 1.00

Endocytosis of glycosylphosphatidylinositol-anchored proteins. J Biomed Sci (2009) 0.91

Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psychiatry (1994) 0.90

In vivo CNS demyelination mediated by anti-galactocerebroside antibody. Acta Neuropathol (1989) 0.83

Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection. Infect Immun (1999) 0.77

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition. J Immunol (1961) 11.21

CHROMATOGRAPHIC SEPARATION OF HUMAN BRAIN GANGLIOSIDES. J Neurochem (1963) 6.22

Immunochemical reactions of lipids. Prog Allergy (1969) 1.61

Properties of antisera to ganglioside GM1 and asialo GM1. J Immunol (1974) 1.19

Gangliosides of peripheral nerve myelin. J Neurochem (1976) 1.15

Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol (1984) 1.12

The chemistry and biology of cholera toxin. CRC Crit Rev Biochem (1980) 1.08

Ganglioside structures and distribution: are they localized at the nerve ending? J Supramol Struct (1978) 1.02

Antiserum to brain gangliosides produces recurrent epileptiform activity. Science (1976) 0.99

Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures. Brain Res (1985) 0.97

The characterization of sphingolipids from neurons and astroglia of immature rat brain. J Neurochem (1974) 0.95

Isolated leptomeninges of the spinal cord: an ideal tool to study inflammatory reaction in EAE. Acta Neuropathol Suppl (1981) 0.93

Further evidence for a specific ganglioside fraction closely associated with myelin. Biochim Biophys Acta (1968) 0.91

In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin. Acta Neuropathol (1981) 0.91

Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis. Demonstration by ELISA and relation to serum in vivo demyelinating activity. J Neuroimmunol (1984) 0.90

Immunochemical studies of isolated human brain ganglioside components. J Neurochem (1969) 0.90

Composition and metabolism of gangliosides in rat peripheral nervous system during development. J Neurochem (1982) 0.89

Sialosylgalactosyl ceramide as a specific marker for human myelin and oligodendroglial perikarya: gangliosides of human myelin, oligodendroglia and neurons. J Neurochem (1979) 0.88

Anti-ganglioside antibodies in multiple sclerosis. J Neurol Sci (1980) 0.87

Myelin gangliosides in vertebrates. J Neurochem (1982) 0.86

Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett (1976) 0.86

Ganglioside receptors and induction of epileptiform activity: cholera toxin and choleragenoid (B subunits). Exp Neurol (1978) 0.85

Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig. J Neurol Sci (1985) 0.85

Antisera against ganglioside GM2: immunochemical and immunohistological studies. Neuropathol Appl Neurobiol (1982) 0.83

Multiple sclerosis-like disease induced in rabbits by immunization with brain gangliosides. Isr J Med Sci (1981) 0.83

Abnormal maturation of cerebral cortex and behavioral deficit in adult rats after neonatal administration of antibodies to ganglioside. Brain Res (1981) 0.80

Restoration of activity for induction of experimental allergic peripheral neuritis by a combination of myelin basic protein P2 and gangliosides from peripheral nerve. Neurosci Lett (1978) 0.79

Gangliosides of the peripheral nervous system of the rat. Life Sci (1975) 0.79

The isolation and lipid composition of myelin-free axons from rat CNS. J Neurochem (1976) 0.78

Antibodies to total brain gangliosides: titer and specificity of antisera. Adv Exp Med Biol (1980) 0.78

Gangliosides as surface antigens on cells isolated from the rat cerebellar cortex. Nature (1977) 0.77

Articles by these authors

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85

Influence of cultural conditions and mutations on the composition of the outer membrane proteins of Escherichia coli. Mol Gen Genet (1976) 5.45

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84

Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest (1994) 3.58

Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery (1993) 3.27

Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res (1989) 3.10

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05

Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 3.03

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99

Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol (1998) 2.97

Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol (1988) 2.93

Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain (2005) 2.88

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med (1999) 2.84

Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity (2001) 2.77

The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature (1995) 2.44

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol (1998) 2.44

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41

Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol (1995) 2.34

Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev (1997) 2.32

A shared antigenic determinant between natural killer cells and nervous tissue. Nature (1984) 2.24

Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol (1992) 2.19

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials. Nat Med (1999) 1.97

Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol (1997) 1.90

Animal models. Ann Neurol (1994) 1.88

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85

Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol (1989) 1.83

The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol (1986) 1.77

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology (2008) 1.76

Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol (1999) 1.75

Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience (1983) 1.75

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol (1993) 1.74

Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol (1999) 1.71

Marker discrimination in deoxyribonucleic acid-mediated transformation of various Pneumococcus strains. J Bacteriol (1975) 1.71

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol (1995) 1.71

In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol (1992) 1.69

Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A (2001) 1.63

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63

Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol (1998) 1.62

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol (1993) 1.59

Interferon-gamma potentiates antibody-mediated demyelination in vivo. Ann Neurol (1992) 1.57

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol (1998) 1.56

The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia (1995) 1.55

Intracerebral targets and immunomodulation of murine Listeria monocytogenes meningoencephalitis. J Neuropathol Exp Neurol (1996) 1.54

Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest (1993) 1.53

Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem (1989) 1.53

An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol (1989) 1.51

Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol (1993) 1.50

Lethal capillary leak syndrome after a single administration of interferon beta-1b. Neurology (1999) 1.49

Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest (1997) 1.47

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain (2000) 1.47

Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science (1991) 1.46

Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology (2002) 1.45

Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem (1993) 1.44

MAP1B is required for axon guidance and Is involved in the development of the central and peripheral nervous system. J Cell Biol (2000) 1.44

Patterns of oligodendroglia pathology in multiple sclerosis. Brain (1994) 1.44

Detection of apoptosis in tissue sections. Cell Tissue Res (2000) 1.43

Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (1990) 1.43

Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses. Eur J Neurol (2003) 1.39

Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J Neuroimmunol (2000) 1.36

Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles. Acta Neuropathol (1987) 1.35

Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol (1998) 1.34

MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest (1998) 1.33

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med (1994) 1.33

Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol (1994) 1.30

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur J Immunol (1999) 1.29

Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J Immunol (2000) 1.28

The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol (2002) 1.28

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol (2001) 1.28

Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol (1990) 1.27

[Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS]. Wien Klin Wochenschr (1966) 1.26

Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J Cell Sci (1993) 1.25

The cerebrohepatorenal (Zellweger) syndrome: an improved method for the biochemical diagnosis and its potential value for prenatal detection. Pediatr Res (1985) 1.25

Review: Mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol (2008) 1.25

Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) (2000) 1.23

Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Arch Neurol (1979) 1.22

Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am J Pathol (1998) 1.21

Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol (1981) 1.21

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol (2004) 1.20

Different types of benign nerve sheath tumors. Light microscopy, electron microscopy and autoradiography. Virchows Arch A Pathol Anat Histol (1977) 1.19

T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am J Pathol (1998) 1.19

Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol (1994) 1.18

Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol (1999) 1.17

Axonal pathology in multiple sclerosis. A historical note. Brain Pathol (1999) 1.17

Chronic relapsing EAE. Time course of neurological symptoms and pathology. Acta Neuropathol (1978) 1.17

Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res (1997) 1.16

Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras. Glia (1995) 1.16

Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. J Immunol (1991) 1.15

Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg (1992) 1.14

Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation. Acta Neuropathol (1990) 1.14

Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand J Immunol (2002) 1.14

Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissues. Neuroscience (1985) 1.14

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol (2001) 1.14

Chronic relapsing experimental allergic encephalomyelitis. Immunohistochemical studies. Arch Neurol (1980) 1.12

Regeneration of a transected peripheral nerve. An autoradiographic and electron microscopic study. Acta Neuropathol (1975) 1.10

[Suture-free interfascicular nerve transplantation in animal experiments]. Wien Med Wochenschr (1972) 1.09

[On the behavior of brain gangliosides in 2 cases of late infantile amaurotic idiocy]. Wien Klin Wochenschr (1968) 1.09